Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (11545)	11/24/1997 2:42:00 PM
From: squetch	Read Replies (2) \| Respond to of 32384

I read in a Hormone Replacement Therapy pamphlet(don't ask) that estrogen doesn't appear to increase the risk of breast cancer. I thought there was an increased risk. An AmCanSoc 9 year study of 422K postmenopausal women reported that the use of hormone therapy was linked ot a significantly decreased risk of fatal breast cancer...For long term use, the incidence of BC might rise from 10 per 10K to 13 per. The only difference I saw was Evista didn't stimulate uterine or breast tissue.